Chronic co-administration of the cannabinoid receptor agonist WIN55,212-2 during puberty or adulthood reverses 3,4 methylenedioxymetamphetamine (MDMA)-induced deficits in recognition memory but not in effort-based decision making

dc.contributor.author	Nagel, Ulrich
dc.contributor.author	Ameln-Mayerhofer, Andreas von
dc.date.accessioned	2013-11-28T15:37:35Z
dc.date.available	2013-11-28T15:37:35Z
dc.date.issued	2013
dc.identifier.issn	0091-3057
dc.identifier.uri	http://hdl.handle.net/10900/38326
dc.language.iso	en	de_DE
dc.publisher	Pergamon - Elsevier Science Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.pbb.2013.03.011	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	150	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Chronic co-administration of the cannabinoid receptor agonist WIN55,212-2 during puberty or adulthood reverses 3,4 methylenedioxymetamphetamine (MDMA)-induced deficits in recognition memory but not in effort-based decision making	de_DE
dc.type	Article	de_DE
utue.quellen.id	20130911224530_00830	de_DE
utue.publikation.seiten	91-100	de_DE
utue.personen.roh	Schulz, Sybille
utue.personen.roh	Becker, Thorsten
utue.personen.roh	Nagel, Ulrich
utue.personen.roh	von Ameln-Mayerhofer, Andreas
utue.personen.roh	Koch, Michael
dcterms.isPartOf.ZSTitelID	Pharmacology Biochemistry and Behavior	de_DE
dcterms.isPartOf.ZS-Volume	106	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE